Lyncean Technologies

About:

Lyncean commercialized a paradigm shift in X-ray technology by shrinking the size/cost of a Synchrotron ($B particle accelerators) by 200x

Website: http://www.lynceantech.com

Top Investors: Intel Capital, EuroUS Ventures, JRR Solutions, Quintus Vermoegensverwaltung GmbH

Description:

Lyncean Technologies, Inc. is located in Fremont, California and was founded in 2001 to develop the Compact Light Source (CLS), a miniature synchrotron x-ray source, based on research performed at the SLAC National Accelerator Laboratory and Stanford University. Unlike stadium-sized synchrotron radiation sources that require a highly technical support staff, the CLS fits in a typical laboratory space and is designed to be operated directly by academic or industrial end-users. By replacing the conventional "undulator" magnets found in the large synchrotrons by laser technology, the entire device scales down in size by a factor of 200. Unlike traditional laboratory sources, the CLS makes a narrow beam of nearly monochromatic X-rays which are adjustable in energy. The first commercial Lyncean CLS was purchased in December 2012 by researchers from the newly formed Center for Advanced Laser Applications in Germany, a joint project of the Ludwig Maximilians University of Munich and the Technical University Munich (TUM). The Munich CLS was delivered at the end of 2014 and has been in routine operation since April 2015. Intellectual property developed at Lyncean Technologies, Inc. is protected by several patents.

Total Funding Amount:

$19.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fremont, California, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)lynceantech.com

Founders:

Jeff Rifkin, Rod Loewen, Ronald Ruth

Number of Employees:

11-50

Last Funding Date:

2018-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai